Latest Breaking News On - Gram positive selective spectrum - Page 9 : vimarsana.com

New to The Street Announces its Corporate Interviews,

NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) FMW Media's New to The Street announces their featured corporate interviews for two episodes, 459 and 460,.

United statesMonica brennanAlain ghiaiJoe endosoJane kingYona shternMonica malpassBiologik groupExchange commissionBusiness development officeAcurx phamaceuticals incHapbee technologies incSecurity mattersSecurities exchangeSecurity matters public limitedSekur private data ltd

Acurx Announces Ibezapolstat Scientific Poster and Update on its Pol IIIC Pipeline Presented at ECCMID 2023 Scientific Conference

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United statesRobertj delucciaUrsula theuretzbacherKevin gareyData monitoring committeeCompany phDrug administrationUniversity of houstonExchange commission on formSociety or healthcare epidemiology of americaInfectious diseases society of americaEuropean society of clinical microbiologyResearch scientist facultyAcurx pharmaceuticals incAcurx pharmaceuticalsUniversity of houston college pharmacy

New to The Street Announces the Televised Lineups for Shows 452, 457, and 458, Airings on Three Networks Will Begin Tonight, Thursday, April 13, 2023, at 9:30 PM ET

New to The Street Announces the Televised Lineups for Shows 452, 457, and 458, Airings on Three Networks Will Begin Tonight, Thursday, April 13, 2023, at 9:30 PM ET
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ohio valleyUnited statesKevin websterTakeshi fuchiwakiPaul adlerMonica brennanMonica malpassJoya dassJonas muthoniJack mcdonaldJoe endosoKyle mcconnellDan batesNancy duitchTim johnsonTony raynor

FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial and Acurx Announces Presentations at ECCMID 2023 Scientific Conference

FDA has accepted an Interim Analysis Plan for an IDMC to assess clinical outcome when 36 patients are enrolled in the Company s Ph2b clinical trial of.

United statesKevin gareyUrsula theuretzbacherRobertj delucciaEuropean society of clinical microbiologyExchange commission on formEuropean congressPrnewswire acurx pharmaceuticals incCompany phInfectious diseases society of americaDrug administrationExchange commissionAcurx pharmaceuticals incTrial oversight committeeUniversity of houston college pharmacyAcurx pharmaceuticals

Acurx Pharmaceuticals (ACXP) Announces FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial

Acurx Pharmaceuticals (ACXP) Announces FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKevin gareyRobertj delucciaUrsula theuretzbacherData monitoring committeeInfectious diseases society of americaInhibitor program for systemic bacterialAcurx pharmaceuticalsUniversity of houston college pharmacyDrug administrationAcurx pharmaceuticals incCompany phEuropean society of clinical microbiologyEuropean congressTrial oversight committeeSociety or healthcare epidemiology of america